"Triple Action Diabetes Control: TRIGLICLAGLAZE 60"

TRIGLICLAGLAZE 60

Gliclazide 60mg (SR) Pioglitazone 15mg and Metformin HCL 500mg(SR)

TRIGLICLAGLAZE 60 combination of Gliclazide 60mg (SR) Pioglitazone 15mg and Metformin HCL 500mg(SR), commonly known as TRIGLICLAGLAZE 60, is a triple combination therapy formulated to effectively manage type 2 diabetes mellitus. This article delves into the individual components of this medication, their synergistic effects, benefits, dosage, and considerations for usage.

Understanding Gliclazide 60mg (SR):

Stimulating Insulin Secretion:

• Gliclazide 60mg (SR) is a sulfonylurea medication that acts by stimulating insulin secretion from pancreatic beta cells.
• Its sustained-release formulation ensures prolonged duration of action, providing consistent blood sugar control throughout the day.

Insight into Pioglitazone 15mg:

Enhancing Insulin Sensitivity:

• Pioglitazone 15mg is a thiazolidinedione (TZD) medication that improves insulin sensitivity in peripheral tissues.
• By activating peroxisome proliferator-activated receptor gamma (PPAR-γ) receptors, it promotes glucose uptake and utilization.

Benefits of Metformin HCL 500mg (SR):

Reducing Hepatic Glucose Production:

• Metformin HCL 500mg (SR) is a biguanide medication that primarily targets hepatic glucose production.
• Its sustained-release formulation minimizes gastrointestinal side effects and improves treatment adherence.

Synergistic Effects of TRIGLICLAGLAZE 60:

Comprehensive Glycemic Control:

• TRIGLICLAGLAZE 60 combines the complementary mechanisms of action of gliclazide 60mg (SR), pioglitazone 15mg, and metformin HCL 500mg (SR).
• This triple action approach provides comprehensive glycemic control by targeting multiple pathways involved in glucose metabolism.

Dosage and Administration Guidelines:

Optimizing Treatment Regimen:

• The recommended dosage of TRIGLICLAGLAZE 60 may vary depending on individual patient characteristics and disease severity.
• Healthcare providers should provide clear instructions on dosage and administration to ensure effective treatment outcomes.

Considerations for Usage:

Patient-Centered Approach:

• Before initiating treatment with TRIGLICLAGLAZE 60, healthcare providers should assess patients' medical history and renal function.
• Regular monitoring of glycemic parameters and renal function is essential to evaluate treatment response and detect potential complications.

Conclusion:

Gliclazide 60mg (SR) Pioglitazone 15mg and Metformin HCL 500mg(SR), marketed as TRIGLICLAGLAZE 60, offers a triple action approach to managing type 2 diabetes mellitus. By combining the insulin secretagogue action of gliclazide 60mg (SR) with the insulin-sensitizing effects of pioglitazone 15mg and metformin HCL 500mg (SR), this medication provides comprehensive glycemic control while minimizing the risk of hypoglycemia and other adverse effects. With proper dosage, administration, and patient monitoring, TRIGLICLAGLAZE 60 serves as a valuable tool in optimizing diabetes management and improving patient outcomes.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW